Genuity


Canaccord Initiates Buy on Synergy Pharmaceuticals Inc; Sees 137% Upside for the Stock

In a research report issued today, Canaccord analyst Corey Davis initiated coverage on shares of Synergy Pharmaceuticals Inc (NASDAQ:SGYP), with a Buy rating and …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts